We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+9.13%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$20.5B
AUM Growth
+$1.31B
Cap. Flow
-$64.5M
Cap. Flow %
-0.31%
Top 10 Hldgs %
30.13%
Holding
1,270
New
254
Increased
410
Reduced
389
Closed
206

Top Sells

Rank Stock Value
1
RY icon
Royal Bank of Canada
RY
+$115M
2
ENB icon
Enbridge
ENB
+$87.8M
3
PFE icon
Pfizer
PFE
+$80.4M
4
CNI icon
Canadian National Railway
CNI
+$78.6M
5
AAPL icon
Apple
AAPL
+$73.1M

Sector Composition

Rank Sector Weight
1 Financials 24.6%
2 Technology 17.8%
3 Industrials 12.95%
4 Communication Services 8.37%
5 Materials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
226
Regeneron Pharmaceuticals
REGN
$82.2B
$11.2M 0.05%
17,739
+5,879
+50% +$3.61M
INVH icon
227
Invitation Homes
INVH
$17.7B
$11.2M 0.05%
246,228
+151,905
+161% +$6.28M
MXL icon
228
MaxLinear
MXL
$6.74B
$11.2M 0.05%
+147,960
New +$9.47M
HBM icon
229
Hudbay
HBM
$12.4B
$10.9M 0.05%
1,510,450
-919,750
-38% -$6.38M
RCUS icon
230
Arcus Biosciences
RCUS
$3.69B
$10.8M 0.05%
266,543
-6,064
-2% -$235K
NSC icon
231
Norfolk Southern
NSC
$75.3B
$10.8M 0.05%
36,217
-2,430
-6% -$678K
PPL
232
PPL Corp
PPL
$26.7B
$10.7M 0.05%
355,801
-32,028
-8% -$924K
GILD icon
233
Gilead Sciences
GILD
$168B
$10.7M 0.05%
147,022
+80,182
+120% +$5.52M
COF icon
234
Capital One
COF
$136B
$10.6M 0.05%
+73,338
New +$11.3M
AOS icon
235
A.O. Smith
AOS
$8.51B
$10.6M 0.05%
123,934
+4,460
+4% +$340K
TAL icon
236
TAL Education Group
TAL
$6.58B
$10.6M 0.05%
2,693,425
+40,694
+2% +$184K
NGG icon
237
National Grid
NGG
$81.1B
$10.5M 0.05%
161,575
+45,975
+40% +$2.7M
SPLK
238
DELISTED
Splunk Inc
SPLK
$10.4M 0.05%
89,992
-50,830
-36% -$7.1M
ATVI
239
DELISTED
Activision Blizzard
ATVI
$10.3M 0.05%
155,450
-139,366
-47% -$9.52M
NVO
240
Novo Nordisk
NVO
$203B
$10.2M 0.05%
182,458
+4,972
+3% +$269K
EXC icon
241
Exelon
EXC
$46.6B
$10.2M 0.05%
247,028
-152,790
-38% -$5.75M
BRO icon
242
Brown & Brown
BRO
$23.8B
$10M 0.05%
142,785
+60,007
+72% +$3.87M
AVGO icon
243
Broadcom
AVGO
$1.98T
$9.99M 0.05%
150,170
+17,220
+13% +$968K
HAPN
244
Happen Inc
HAPN
$2.25B
$9.8M 0.05%
405,269
+10,546
+3% +$357K
JAZZ icon
245
Jazz Pharmaceuticals
JAZZ
$16.2B
$9.74M 0.05%
76,419
+35,552
+87% +$4.67M
V icon
246
Visa
V
$671B
$9.7M 0.05%
44,775
-195,981
-81% -$42.1M
GD icon
247
General Dynamics
GD
$107B
$9.68M 0.05%
46,444
+15,089
+48% +$3.05M
WIX icon
248
WIX.com
WIX
$2.88B
$9.23M 0.05%
58,494
-41,091
-41% -$7.13M
PSA icon
249
Public Storage
PSA
$60.4B
$9.19M 0.04%
24,543
-19,263
-44% -$6.43M
MUR icon
250
Murphy Oil
MUR
$5.06B
$8.97M 0.04%
343,685
-215,927
-39% -$5.97M

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q4 2021 Portfolio in Review

As of Q4 2021, Connor, Clark & Lunn Investment Management (CC&L) held 1,270 positions worth $20.5B, up 6.8% from $19.2B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L)'s Q4 2021 filing shows 254 new, 410 increased, 389 reduced and 206 closed positions. Its largest new stake was Nuvei Corporation Subordinate Voting Shares: 879,610 shares worth $57.1M. The largest sale was Royal Bank of Canada, an estimated $115M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q4 2021 buy was Nuvei Corporation Subordinate Voting Shares: 879,610 shares worth $57.1M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Waste Connections in Q4 2021, an estimated $102M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q4 2021 reduction was Royal Bank of Canada, cutting an estimated $115M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Edwards Lifesciences in Q4 2021, selling an estimated $26.6M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 30% of its $20.5B portfolio in Q4 2021.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 254 new positions and closed 206 in Q4 2021.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 6.8% quarter-over-quarter to $20.5B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2021, filed 10 Feb 2022.